Ledger.Open graph →
SEC Form D · filed September 14, 2020

AZIYO BIOLOGICS, INC

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SILVER SPRING, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Jeffrey D. Hamet · Silver Spring, MDExecRonald D. Lloyd · Silver Spring, MDExec · DirectorCharles R. Mills · Silver Spring, MDDirectorKevin R. Rakin · Silver Spring, MDDirectorWilliam M. Zuga · Silver Spring, MDDirectorAndrew Sandler · New York, NYDirectorMitchell M. London · Redmond, WAExec · DirectorRalph Woodford · Grand Cayman, Cayman IslandsExecGregory Link · Grand Cayman, Cayman IslandsDirectorMark Lappe · La Jolla, CADirectorSteven R. Hochberg · Silver Spring, MDDirectorRonald Shaich · Washington, Washington, D.C.DirectorWilliam Burkoth · Ann Arbor, MIDirectorNicole Walker · Ann Arbor, MIExecEric W. Jacobsen · Lake Oswego, ORDirectorKokila Doshi · San Diego, CAExec · DirectorSteven R. Hochberg · Silver Spring, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗